ONCOLYTICS BIOTECH INC. Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss
ONCOLYTICS BIOTECH INC. (ONCY) reported Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss of CAD 961.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-03-07.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss · last filed 2025-03-07
| Period end | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month as first filed |
|---|---|---|
| 2024-12-31 | 961.00K CAD 20-F · filed 2025-03-07 | |
| 2023-12-31 | -475.00K CAD 20-F · filed 2025-03-07 | |
| 2022-12-31 | 1.67M CAD 20-F · filed 2025-03-07 | |
| 2021-12-31 | -136.00K CAD 20-F · filed 2024-03-12 | -135.64K CAD 20-F · filed 2022-03-03 |
| 2020-12-31 | -659.00K CAD 20-F · filed 2023-03-03 | -659.17K CAD 20-F · filed 2021-03-05 |
| 2019-12-31 | -316.72K CAD 20-F · filed 2022-03-03 | |
| 2018-12-31 | 610.11K CAD 20-F · filed 2021-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |